CGC
Canopy Growth Corp.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$0.93
−0.50%Next report
Analyst consensus
- Next report date
- Nov 6, 2026
- EPS estimate
- -$0.03
- Revenue estimate
- $60.3M
Latest reported
- Last report date
- Aug 7, 2026
- EPS actual
- -$0.02
- EPS estimate
- -$0.04
- Revenue actual
- $57.2M
- Revenue estimate
- $58.9M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 8
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -68.9%
- Revenue beats (12Q)
- 3
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 7, 2026 | -$0.04 | -$0.02 | Beat 50.00% | $57.2M |
| Jun 15, 2026 | -$0.06 | -$0.17 | Miss -183.33% | $51.2M |
| Feb 6, 2026 | -$0.03 | -$0.10 | Miss -233.33% | $90.4M |
| Nov 7, 2025 | -$0.11 | -$0.01 | Beat 90.91% | $66.7M |
| Aug 8, 2025 | -$0.15 | -$0.14 | Beat 6.67% | $52.8M |
| May 30, 2025 | -$0.10 | -$0.94 | Miss -840.00% | $44.5M |
| Feb 7, 2025 | -$0.38 | -$0.76 | Miss -100.00% | $51.9M |
| Nov 8, 2024 | -$0.38 | -$0.95 | Miss -150.00% | $46.6M |
| Aug 9, 2024 | -$0.31 | -$0.37 | Miss -19.35% | $48.4M |
| May 30, 2024 | -$0.33 | -$0.28 | Beat 15.15% | $53.6M |
| Feb 9, 2024 | -$0.45 | -$1.79 | Miss -297.78% | $59.1M |
| Nov 9, 2023 | -$1.20 | -$1.80 | Miss -50.00% | $51.4M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 6, 2026